Enliven Therapeutics, Inc.ELVNNASDAQ
Loading
Year-over-year total asset growth rate
Latest
-3.00%
↓ 115% vs avg
Percentile
P44
Within normal range
Streak
2 qtr
Consecutive declineDecelerating
Average
19.89%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | -3.00% |
| Q3 2025 | -2.58% |
| Q2 2025 | 66.54% |
| Q1 2025 | -7.12% |
| Q4 2024 | 6.66% |
| Q3 2024 | -6.61% |
| Q2 2024 | -4.59% |
| Q1 2024 | 26.08% |
| Q4 2023 | -0.79% |
| Q3 2023 | -5.01% |
| Q2 2023 | -4.74% |
| Q1 2023 | 263.59% |
| Q4 2022 | -8.26% |
| Q3 2022 | 40.41% |
| Q2 2022 | -20.75% |
| Q1 2022 | -28.00% |
| Q4 2021 | 5.89% |
| Q3 2021 | 47.69% |
| Q2 2021 | -11.29% |
| Q1 2021 | -10.08% |
| Q4 2020 | -9.32% |
| Q3 2020 | -10.01% |
| Q2 2020 | 0.90% |
| Q1 2020 | 231.32% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |